As 2024 has come to an end, our loyal readers have joined us in reviewing our ten worst decisions of the past year and our ten (plus runners up) best decisions of the past year.
As we do each year, we’re pleased to announce that four of your bloggers – Bexis, Steven Boranian, Stephen McConnell, and Lisa Baird – will be presenting a free 90-minute CLE webinar on “The Good, the Bad and the Ugly: The best and worst drug/medical device decisions of 2024” on Thursday, January 16th at 12 p.m. EST to provide further insight and analysis on these cases.
This program is presumptively approved for 1.5 CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas and West Virginia. Applications for CLE credit will be filed in Delaware, Florida, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance but Reed Smith only provides credit for the states listed. Please allow 4-6 weeks after the program to receive a certificate of attendance.
Additionally, please note that CLE credit for on-demand viewing is only available in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas, and West Virginia. Credit availability expires two years from the date of the live program. In order to receive CLE credit, you will need to notify Learning & Development CLE Attendance once you have viewed the program on-demand.
The program is free and open to anyone interested in tuning in, but you have to sign up in advance here.